Cargando…

The management of post-transplantation recurrence of hepatocellular carcinoma

The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades, liver transplantation (LT) has become the preferable treatment of HCC, when feasible and strict selection criteria are met. With the rise in HCC-related LT, compounded by downstaging techniques and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajendran, Luckshi, Ivanics, Tommy, Claasen, Marco PAW, Muaddi, Hala, Sapisochin, Gonzalo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755475/ https://www.ncbi.nlm.nih.gov/pubmed/34610652 http://dx.doi.org/10.3350/cmh.2021.0217

Ejemplares similares

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma(✰)()
por: Claasen, Marco P.A.W., et al.
Publicado: (2023)

Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis
por: Yoon, Peter D., et al.
Publicado: (2022)

Trends in liver transplantation for autoimmune liver diseases: a Canadian study
por: Murillo Perez, Carla F., et al.
Publicado: (2022)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

The New Era of Transplant Oncology: Liver Transplantation for Nonresectable Colorectal Cancer Liver Metastases
por: Gorgen, Andre, et al.
Publicado: (2018)

Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
por: Choi, Woo Jin, et al.
Publicado: (2023)

Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
por: Gringeri, Enrico, et al.
Publicado: (2020)

National time trends in mortality and graft survival following liver transplantation from circulatory death or brainstem death donors
por: Wallace, David, et al.
Publicado: (2021)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2022)

Long-term outcomes of ablation, liver resection, and liver transplant as first-line treatment for solitary HCC of 3 cm or less using an intention-to-treat analysis: A retrospective cohort study
por: Ivanics, T., et al.
Publicado: (2022)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation—Adjusting the Odds?
por: Seehofer, Daniel, et al.
Publicado: (2022)

Call to Improve the Quality of Prediction Tools for Intrahepatic Cholangiocarcinoma Resection: A Critical Appraisal, Systematic Review, and External Validation Study
por: Choi, Woo Jin, et al.
Publicado: (2023)

Dual‐Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma
por: Chen, Kui, et al.
Publicado: (2021)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Recent advances in liver transplantation for cancer: The future of transplant oncology
por: Abreu, Phillipe, et al.
Publicado: (2019)

“Teamwork makes the dream work”- interdisciplinary team dynamics within the operating room
por: Rajendran, Luckshi
Publicado: (2022)

The emotional brainbow
por: Rajendran, Luckshi
Publicado: (2019)

A surgeon’s paintbrush
por: Rajendran, Luckshi
Publicado: (2021)

Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm
por: Au, Kin Pan, et al.
Publicado: (2018)

Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2012)

Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
por: Sehjal, Jyoti, et al.
Publicado: (2022)

Liver Transplant Recipient Characteristics Associated With Worse Post-Transplant Outcomes in Using Elderly Donors
por: Shimada, Shingo, et al.
Publicado: (2022)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence
por: Rahimi, Robert S., et al.
Publicado: (2015)

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
por: Citores, Maria J, et al.
Publicado: (2019)

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation
por: Jhaveri, Kartik S., et al.
Publicado: (2023)

Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
por: Bzeizi, Khalid I., et al.
Publicado: (2022)

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation
por: Degroote, Helena, et al.
Publicado: (2022)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2015)

Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma
por: Sapisochin, Gonzalo, et al.
Publicado: (2022)

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
por: Straś, Wojciech Andrzej, et al.
Publicado: (2022)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l9f1asfpflem74j610ltvbdnm1